{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:01Z","timestamp":1791925321506,"version":"4.3.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s13181-010-0047-0","type":"journal-article","created":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T19:16:26Z","timestamp":1270062986000},"page":"322-326","source":"Crossref","is-referenced-by-count":56,"title":["Severe Drug-induced Liver Injury Associated with Prolonged Use of Linezolid"],"prefix":"10.1007","volume":"6","author":[{"given":"Liesbet","family":"De Bus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Depuydt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Libbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linos","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Nollet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Vogelaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00002018-200831090-00004","volume":"31","author":"ME Falagas","year":"2008","unstructured":"Falagas ME, Vardakas KZ (2008) Benefit\u2013risk assessment of linezolid for serious Gram-positive bacterial infections. Drug Saf 31:753\u2013768","journal-title":"Drug Saf"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1128\/AAC.50.4.1599-1602.2006","volume":"50","author":"E Bishop","year":"2006","unstructured":"Bishop E, Melvani S, Howden BP, Charles PGP, Grayson ML (2006) Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients. Antimicrob Agents Chemother 50:1599\u20131602","journal-title":"Antimicrob Agents Chemother"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/tcrm.2006.2.4.455","volume":"2","author":"R Manfredi","year":"2006","unstructured":"Manfredi R (2006) Update on the appropriate use of linezolid in clinical practice. Ther Clin Risk Manag 2:455\u2013464","journal-title":"Ther Clin Risk Manag"},{"issue":"S1","key":"47_CR4","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","volume":"59","author":"DC Vinh","year":"2009","unstructured":"Vinh DC, Rubinstein E (2009) Linezolid: a review of safety and tolerability. J Infect 59(S1):S59\u2013S74","journal-title":"J Infect"},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","volume":"349","author":"ML William","year":"2003","unstructured":"William ML (2003) Drug-induced hepatotoxicity. N Engl J Med 349:474\u2013485","journal-title":"N Engl J Med"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","volume":"30","author":"G Abboud","year":"2007","unstructured":"Abboud G, Kaplowitz N (2007) Drug-induced liver injury. Drug Saf 30:277\u2013294","journal-title":"Drug Saf"},{"key":"47_CR7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/jhep.2001.20645","volume":"33","author":"MI Lucena","year":"2001","unstructured":"Lucena MI, Camargo R, Andrade RJ et al (2001) Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 33:123\u2013130","journal-title":"Hepatology"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2036.2008.03655.x","volume":"27","author":"M Garcia-Cort\u00e9s","year":"2008","unstructured":"Garcia-Cort\u00e9s M, Lucena MI, Pachkoria K et al (2008) Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 27:780\u2013789","journal-title":"Aliment Pharmacol Ther"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/14740338.6.6.673","volume":"6","author":"SH Hussaini","year":"2007","unstructured":"Hussaini SH, Farrington EA (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opin Drug Saf 6:673\u2013684","journal-title":"Expert Opin Drug Saf"},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(97)80496-5","volume":"26","author":"B Fromenty","year":"1997","unstructured":"Fromenty B, Pessayre D (1997) Impaired mitochondrial function in microvesicular steatosis. J Hepatol 26:43\u201353","journal-title":"J Hepatol"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0168-8278(97)82328-8","volume":"26","author":"B Fromenty","year":"1997","unstructured":"Fromenty B, Berson A, Pessayre D (1997) Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 26:13\u201322","journal-title":"J Hepatol"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","volume":"22","author":"G Labbe","year":"2008","unstructured":"Labbe G, Pessayre D, Fromenty B (2008) Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol 22:335\u2013353","journal-title":"Fundam Clin Pharmacol"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","volume":"50","author":"EE McKee","year":"2006","unstructured":"McKee EE, Ferguson M, Bentley AT, Marks TA (2006) Inhibition of mammalian mitochondrial protein synthesis. Antimicrob Agents Chemother 50:2042\u20132049","journal-title":"Antimicrob Agents Chemother"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","volume":"42","author":"AS Vriese De","year":"2006","unstructured":"De Vriese AS, Van Coster A, Smet J et al (2006) Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 42:1111\u20131117","journal-title":"Clin Infect Dis"},{"key":"47_CR15","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/AAC.01190-06","volume":"51","author":"G Garrabou","year":"2007","unstructured":"Garrabou G, Soriano A, Lopez S et al (2007) Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother 51:962\u2013967","journal-title":"Antimicrob Agents Chemother"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jac\/46.3.347","volume":"46","author":"DM Livermore","year":"2000","unstructured":"Livermore DM (2000) Quinupristin\/dalfopristin and linezolid: where, when, which and whether to use? J Antimicrob Chemother 46:347\u2013350","journal-title":"J Antimicrob Chemother"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1128\/AAC.01411-05","volume":"50","author":"EE McKee","year":"2006","unstructured":"McKee EE, Ferguson M, Bentley AT et al (2006) Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother 50:2042\u20132049","journal-title":"Antimicrob Agents Chemother"},{"key":"47_CR18","first-page":"367","volume-title":"MacSween\u2019s pathology of the liver","author":"EM Brunt","year":"2007","unstructured":"Brunt EM (2007) Non alcoholic fatty liver disease. In: MacSween RNM, Burt AD, Portmann BC, Ferrell LD (eds) MacSween\u2019s pathology of the liver, 5th edn. Elsevier Health Sciences, Amsterdam, pp 367\u2013398","edition":"5"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gtc.2007.01.009","volume":"36","author":"A Ukleya","year":"2007","unstructured":"Ukleya A, Romano MM (2007) Complications of parenteral nutrition. Gastroenterol Clin N Am 36:23\u201346","journal-title":"Gastroenterol Clin N Am"},{"issue":"8","key":"47_CR20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","volume":"30","author":"P Linden","year":"2007","unstructured":"Linden P (2007) Safety profile of meropenem. Drug Saf 30(8):657\u2013668","journal-title":"Drug Saf"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-010-0047-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-010-0047-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-010-0047-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T17:23:10Z","timestamp":1559582590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-010-0047-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s13181-010-0047-0","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,1]]}}}